Latest newsLATEST NEWS

We aim to become one of the leading pharmaceutical companies and to do all in our power to help prevent infectious diseases.

2018/04/17
MVC Gets Listed on OTC Market on April 17th
see more
2017/12/25
MVC Obtained Taiwan OTC Market Approval
see more
2017/10/23
MVC Co-organized International Forum for Dengue Prevention and Vaccine Development
see more
2017/09/28
TFDA Approves Dengue Vaccine's Phase 2 POC Clinical Trial
see more
2017/09/18
US NIH Expands Existing License Agreement with MVC for Dengue Vaccine from 17 to 26 Countries
see more
2017/08/01
MVC Gets TFDA's Nods to Start Phase 3 CT for EV71 Vaccine
see more
We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our use of cookies. Our Privacy & Cookie Policy contains more information on such use and explains how to disable cookies.
Agree